Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

January 30, 2024 Rich Daly Editor in Chief Views

The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly